To further confirm the independent diagnostic role of CBXs in GBM, we performed Cox survival regression analysis, including the CBX family, gender, age, radiotherapy, chemotherapy, IDH mutation, and 1p19q codeletion. This evidence concerns the gene CBX1 and glioblastoma.